General Therapeutics is developing next-generation lipid nanoparticle (LNP) platforms that enable safer, targeted, and scalable in vivo genetic therapies. Its proprietary technologies, including non-reactogenic ionizable lipids (iLDC™) and one-step targeted LNP manufacturing (POLAR™), address key ch... Read more
Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
